That is essential, due to the fact that the method a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and be reliable. To put it simply, we have to understand how these proteins fold if we desire a drug to work. Historically, this has actually been a trial-and-error procedure (social media). However now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're designed to do. This was a development nearly no one noticed. But it's going to have extensive ramifications for curing disease. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be a lot of investment opportunities in this space, too. Moving subjects It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (jeff brown stock picks 2021). That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be amazed if it drew back maybe substantially before going higher - melania trump. I've been covering bitcoin for a very long time now. Among the very first research study reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I titled my report "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time. We were mostly informing readers. However that's not the big question any longer. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche business. Mass, Mutual is a relied on 170-year-old institution. So believe about that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big factor I'm bullish on it this year. jeff brown investment prediction. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are numerous fantastic private companies on the verge of striking the general public markets And I've been dealing with a new way for you to invest even prior to these companies go public.
This opportunity has been building over the last couple of years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the details. Go right here to schedule your area for complimentary.
Emma Walsh here, managing editor of the Diary. Routine Journal readers know that tech isn't our typical beat (jeff brown biotech genome sequencing). And when it concerns tech investing, we leave it to the specialists. Thankfully, we have several such professionals in our Rolodex. Our colleague Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing professionals we understand (tech stocks). In reality, he had a number of triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big picture and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and a lot more. These patterns are experiencing rapid growth and developing unbelievable opportunities for financiers. I wish to make sure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a subject I've been covering for years now. second wave. But regardless of what many readers may believe, this is a trend that's simply getting begun. Although the COVID-19 pandemic interfered with supply chains last year, an impressive 250 million 5G-enabled gadgets were still offered.
And all of this eventually led to Apple postponing the release of the 5G-enabled i, Phone 12 by two months (brownstone research stock). Losing two months of production and sales really impacts how many 5G devices are offered in the calendar year. When you think about all of that, offering 250 million units is impressive. More importantly, the delays triggered by the pandemic developed a heap of suppressed need. Which demand is now going to be pushed into 2021. In truth, I predict that more than 500 million 5G gadgets will be delivered in 2021 - jeff brown predictions for 2021. Which's not my only 5G prediction When I've talked about 5G in the past, I have actually described its three various phases.
In Phase 2, 5G gadgets go on sale. 5G phones and other products begin to reach customers. And in Stage 3, 5G services begin to be offered (jeff brown 1 biotech). That's when we begin to see applications operating on 5G networks. Think of things like massive multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will start Stage Three by this summer. This begins something of a virtuous cycle: The majority of people do not actually care about the technology. But they will care if there are interesting applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In truth, 5G is going to open up a suite of unbelievable applications: self-driving automobiles, the Internet of Things, robotic surgery, and more. All of these technologies need 5G. The investment opportunities moving forward will be massive. Stepping away from 5G, the next crucial innovation I predict in 2021 is CRISPR hereditary modifying. CRISPR means "clustered routinely interspaced brief palindromic repeat." It's a mouthful. However it is among the most interesting advancements in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software.
The program can crash or not work correctly. CRISPR uses a comparable concept however with our hereditary code. "Typos" in our genome can cause illness. CRISPR can fix these "typos." For years, CRISPR was primarily a specific niche technology that wasn't well comprehended. And during that time, there were actually just three business operating in this space. But things are changing. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're dealing with diseases and seeing that this technology just works. And as a result, a "2nd crop" of early-stage CRISPR business is going public and providing incredible returns. This entire market is successfully a greenfield opportunity.
There's space for lots of business to exist in this space. jeff brown investor prediction. And there will be more. That's my prediction for CRISPR in 2021. I forecast that 2 or three more hereditary editing companies will hold their IPOs. Sticking with biotechnology, we are seeing fantastic things happening at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its newest Alpha, Fold software application can accurately forecast the folding of a protein based entirely on its amino acid series with 92. 4% accuracy. That is necessary because the method a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has actually been a trial-and-error procedure. Now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much easier to develop drugs that do what they're developed to do. And here's my next prediction. I predict that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one but a number of drug therapies produced using this technology. This was among those developments that practically nobody noticed. However it's going to have extensive ramifications for treating illness. And, of course, there will be plenty of investment chances in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be amazed if it pulled back maybe substantially before going greater. I have actually been covering bitcoin for a very long time now. Among the very first research reports I ever published was on bitcoin - biotech stocks jeff brown. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for anybody who followed my recommendation. But at the time of that preliminary suggestion, I entitled my report, "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time.
But nobody is asking that question anymore. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. united arab emirates. Mass, Mutual is a 150-year-old organization. So think about that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another benefit prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and claims the info is up to date since February 2021, however we could not separately verify this claim. Provided Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down an accurate figure at this minute. Brown is best known for his sage-like capability to pick winning innovation stocks. He spent more than 25 years researching innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience offers him an outstanding viewpoint on the market. He's constantly on the hunt for new opportunities, and he shares much of his finest choices in the Future Report.
That's high praise, however it's not ridiculously reasoned. Brown has an excellent credibility as a stock-picker, and he successfully forecasted some of the most significant economic events of the previous twenty years. Although he does not appear to release his picks to the public, the service's success is a direct sign of Brown's stock-picking expertise. No one on Wall Street gets it best each time, but Jeff Brown's accurate forecasts have made him legions of devoted fans. That states a lot about his capability. The Near Future Report is released by Brownstone Research, a prominent monetary research study publisher. Brownstone Research provides several research study services with a variety of expertises - biotech stocks.
The business is also associated with Bonner & Partners, another well-respected research publisher - jeff brown. On its site, Brownstone states its mission is to offer retail financiers with professional-grade research study: "For too long, the very best investment research has actually not been offered to private financiers. It has been generally booked for financial investment banks, hedge funds, private equity, and high-net-worth customers. jeff brown predictions 2021. The mission of Brownstone Research is to make that sort of proprietary research available to any financiers wanting to gain an edge in the marketplaces. The objective is simple to provide distinct and profitable financial investment research found nowhere else." -Brownstone Research study website excerpt from the Jeff Brown is the founder of Brownstone Research, and he likewise functions as the company's Chief Investment Analyst.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to offer its clients. After years of consistent success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a family name throughout most of America. If you understand even a little bit about the marketplace, you understand that he has a track record as a King Midas of sorts. jeff brown biotech genome sequencing. Everything he touches turns to gold! Jeff is aware of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big task.
In fact, Brown thinks S.A.V. tech predictions. could be "the most significant pattern of the 2020s, and he's not alone. Check out these quotes from other well-known S.A.V. bulls: Elon's next big act will be weding 2 cutting-edge technologies: artificial intelligence and electric vehicles. Musk hopes the combination will help him establish the very first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing short of the automobile market's Holy Grail. As you understand, electrical lorries and self-driving automobile stocks have actually been substantial this year, however the Wall Street maker has been big on buzz without much concrete result. Despite an extreme boost in competitors over the previous couple of years, Brown still believes Musk has the finest chance of putting everything together.
tech could be the magic string that ties all of it together. S.A.V. stands for Shared Autonomous Vehicle, and it could be the future of transportation. Generally, this innovation would allow you to lease your car as a self-governing, self-driving taxi when you're not using it. You just leave the automobile and press a button on an app that informs the automobile to "join the fleet." Next thing you understand, you're relaxing on your couch while your car shuttles ride-sharers around town. Most importantly, you get to keep a significant chunk of the revenues. It sounds ridiculous, but it could be closed than you believe.